Segment Information - Schedule of Performance and Making Key Decisions Regarding Resource (Details) - USD ($) |
3 Months Ended | 4 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Schedule of Performance and Making Key Decisions Regarding Resource [Abstract] | |||||
| Cash | $ 66,988 | $ 66,988 | $ 913,121 | ||
| Investments held in Trust Account | 239,633,441 | 239,633,441 | $ 235,449,992 | ||
| Formation, general, and administrative costs | 222,741 | $ 98,348 | $ 131,429 | 1,206,047 | |
| Advisory fee expense | 6,900,000 | 6,900,000 | |||
| Dividend and interest earned on investments held in Trust Account | $ 2,103,913 | $ 761,540 | $ 761,540 | $ 4,183,449 | |
| X | ||||||||||
- Definition The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|